Probiotics for Gut Health: Strain-Specific Guide to Microbiome Support

Dysbiosis and microbiome imbalance affect 70 percent of adults, causing digestive discomfort, weakened immunity, and systemic inflammation that research links to obesity, autoimmune conditions, and metabolic disease. The Designs for Health Anaerostipes Probiotic delivers 1 billion AFU of butyrate-producing bacteria specifically studied for gut barrier health, microbiome balance, and immune function at $39.95 for a 30-day supply. Clinical trials show butyrate-producing strains reduce intestinal permeability, strengthen tight junction proteins, and decrease systemic inflammation markers by 30-40 percent compared to placebo. For budget-conscious buyers, the NatureWise Probiotics 60 Billion CFU at $24.99 provides 17 researched strains with organic prebiotics for comprehensive digestive and immune support. Here’s what the published research shows about probiotics for gut health, immune function, and microbiome restoration.

Disclosure: We may earn a commission from links on this page at no extra cost to you. Affiliate relationships never influence our ratings. Full policy →

How Does Your Gut Microbiome Support Overall Health?

The human gut microbiome contains approximately 100 trillion microorganisms, comprising over 1,000 different species of bacteria alone. These microbes collectively weigh about 2-3 pounds and contain more genetic material than all the cells in your body combined. The composition of your microbiome is as unique as your fingerprint, influenced by factors including genetics, birth method, early life exposures, diet, medications, stress levels, and environmental factors.

A healthy microbiome exhibits high diversity, meaning it contains many different species of beneficial bacteria. This diversity is associated with better metabolic health, stronger immune function, lower inflammation, and reduced risk of chronic diseases (PubMed: 23985870). Conversely, reduced microbial diversity—a condition called dysbiosis—has been linked to inflammatory bowel disease, obesity, type 2 diabetes, cardiovascular disease, allergies, autoimmune conditions, and even neurological disorders like depression and Parkinson’s disease (PubMed: 22699609).

The gut microbiome performs numerous essential functions:

Metabolic Functions: Gut bacteria ferment dietary fibers that humans cannot digest, producing short-chain fatty acids (SCFAs) like butyrate, propionate, and acetate. These compounds serve as fuel for colon cells, regulate metabolism, influence appetite hormones, and possess anti-inflammatory properties throughout the body.

Immune Modulation: Approximately 70-80 percent of your immune system resides in or near the gut. The microbiome trains immune cells to distinguish between harmless substances and genuine threats, regulates inflammatory responses, and produces antimicrobial compounds that reduce pathogen colonization.

Barrier Function: Beneficial bacteria strengthen the intestinal barrier by promoting tight junction proteins that seal the spaces between gut lining cells. This helps reduce leaky gut, where bacterial components and undigested food particles cross into the bloodstream, triggering systemic inflammation.

Synthesis of Essential Compounds: Gut bacteria produce vitamins including vitamin K, several B vitamins (B12, biotin, folate), neurotransmitters like serotonin and GABA, and other bioactive compounds that influence health throughout the body.

Protection Against Pathogens: Beneficial bacteria compete with harmful microbes for nutrients and attachment sites, produce antimicrobial substances, and maintain an acidic pH that inhibits pathogen growth.

When this complex ecosystem becomes imbalanced through antibiotic use, poor diet, chronic stress, infections, or other factors, the consequences extend far beyond digestive discomfort. This is where probiotics enter the picture as a targeted intervention to restore beneficial bacteria and their associated health benefits.

What Are Probiotics and How Do They Work?

Probiotics are defined by the World Health Organization and Food and Agriculture Organization as “live microorganisms that, when administered in adequate amounts, confer a health benefit on the host.” The key terms here are “live,” “adequate amounts,” and “health benefit”—all of which must be substantiated through rigorous research for specific strains.

The most commonly studied probiotic genera include:

Lactobacillus species: These lactic acid-producing bacteria naturally inhabit the small intestine, vagina, and oral cavity. Different Lactobacillus strains have been studied for digestive health, immune support, vaginal health, and more.

Bifidobacterium species: These bacteria dominate the large intestine and are particularly abundant in healthy infants. Bifidobacterium levels tend to decline with age, making supplementation potentially beneficial for older adults.

Saccharomyces boulardii: Unlike bacterial probiotics, this is a beneficial yeast that has shown particular efficacy for preventing and treating diarrhea, including antibiotic-associated diarrhea and traveler’s diarrhea.

Streptococcus thermophilus: Commonly used in yogurt production, this bacterium aids lactose digestion and has demonstrated immune-modulating properties.

Bacillus species: Spore-forming bacteria like Bacillus coagulans are highly stable and can survive stomach acid more effectively than other probiotic species.

Probiotics exert their beneficial effects through multiple mechanisms:

Competitive Exclusion: Probiotics compete with pathogenic bacteria for nutrients and attachment sites on the intestinal lining, physically preventing harmful microbes from establishing colonization.

Production of Antimicrobial Substances: Many probiotic strains produce organic acids (lactic acid, acetic acid), hydrogen peroxide, and bacteriocins—proteins that directly inhibit or kill pathogenic bacteria.

Strengthening Barrier Function: Certain strains increase production of mucin (the protective mucus layer) and tight junction proteins that seal gaps between intestinal cells, reducing intestinal permeability.

Immune System Modulation: Probiotics interact with immune cells in the gut-associated lymphoid tissue (GALT), influencing the balance between pro-inflammatory and anti-inflammatory responses. They can enhance the activity of natural killer cells, increase secretory IgA production, and promote regulatory T cells that reduce excessive inflammation (PubMed: 24912386).

SCFA Production: While transient probiotic bacteria may not permanently colonize the gut, they can still ferment dietary fibers during their passage through the digestive tract, contributing to SCFA production with its associated metabolic and anti-inflammatory benefits.

Bile Salt Metabolism: Some probiotic strains can metabolize bile salts, influencing cholesterol metabolism and potentially contributing to cardiovascular health.

Our Top Pick

Best Overall: Designs for Health Anaerostipes Probiotic

Check Price

Designs for Health Anaerostipes Probiotic - 1 Billion AFU of Butyrate-Producing Probiotics for Gut Health Support, Mi...

Check Price on Amazon

As an Amazon Associate we earn from qualifying purchases.

The Designs for Health Anaerostipes Probiotic represents next-generation probiotic science with 1 billion AFU of Anaerostipes species specifically studied for butyrate production. Unlike traditional Lactobacillus and Bifidobacterium strains, Anaerostipes bacteria produce butyrate as their primary metabolic byproduct, directly supporting gut barrier function, reducing inflammation, and promoting microbiome diversity.

Clinical research on butyrate-producing bacteria shows significant improvements in intestinal permeability markers, enhanced tight junction protein expression, and reduced systemic inflammation compared to standard probiotic formulations. Butyrate serves as the preferred fuel source for colonocytes (colon cells), supporting barrier integrity and reducing risk of leaky gut syndrome.

This formulation provides 1 billion active fluorescent units (AFU) per capsule using advanced stability technology. The gluten-free, dairy-free formula suits various dietary restrictions while maintaining high bacterial viability through expiration. Recommended dosing is one capsule daily, ideally with meals to enhance survival through stomach acid.

The Anaerostipes strain targets specific mechanisms beyond general probiotic effects. Research demonstrates butyrate-producing species support regulatory T cell development, modulate immune responses, influence metabolic signaling pathways, and provide anti-inflammatory benefits throughout the body, not just the digestive tract.

While the price point exceeds traditional probiotics, the targeted butyrate production and emerging clinical evidence supporting metabolic and barrier function benefits justify the premium for individuals specifically seeking gut barrier support, inflammatory condition management, or next-generation microbiome restoration approaches.

Our Top Pick

Best Budget: NatureWise Probiotics 60 Billion CFU

Check Price

NatureWise Probiotics 60 Billion CFU - 17 Strains + Organic Prebiotics - Immune, Digestive & Gut Health Support for W...

Check Price on Amazon

As an Amazon Associate we earn from qualifying purchases.

The NatureWise Probiotics 60 Billion CFU delivers exceptional value with 17 clinically studied strains providing comprehensive digestive, immune, and microbiome support at an affordable price point. The high-potency formula combines diverse Lactobacillus and Bifidobacterium species with organic prebiotic fiber to feed beneficial bacteria.

The delayed-release capsules protect bacterial viability through stomach acid, ensuring strains reach the intestines where they exert beneficial effects. Third-party testing verifies potency and purity, addressing common concerns about probiotic product quality and label accuracy.

The strain diversity provides broad-spectrum benefits including digestive comfort, bowel regularity, immune function, and microbiome balance. Research shows multi-strain formulas often produce superior results compared to single-strain products due to synergistic effects and broader metabolic capabilities.

Organic prebiotic inclusion enhances probiotic effectiveness by providing food sources that support bacterial growth and SCFA production. The combination creates a synbiotic effect maximizing benefits while supporting existing beneficial bacteria already present in your microbiome.

At under $25 for a month’s supply, this formula provides clinically meaningful CFU counts and researched strains at a price point accessible for long-term daily use. The shelf-stable formulation eliminates refrigeration requirements, improving convenience for travel and storage.

Our Top Pick

Best for IBS: Physician's CHOICE Probiotics 60 Billion CFU

Check Price

Physician's CHOICE Probiotics 60 Billion CFU - 10 Strains + Organic Prebiotics - Immune, Digestive & Gut Health - Sup...

Check Price on Amazon

As an Amazon Associate we earn from qualifying purchases.

The Physician’s CHOICE Probiotics 60 Billion CFU combines 10 extensively researched strains specifically selected for IBS symptom management, bloating reduction, and digestive comfort. Clinical studies on similar multi-strain Bifidobacterium and Lactobacillus combinations show 30-40 percent reductions in IBS symptoms including abdominal pain, bloating, and bowel irregularity.

The targeted strain selection emphasizes species with published research supporting digestive health applications. Bifidobacterium strains dominate the formula since research demonstrates particular efficacy for IBS management across all subtypes (IBS-C, IBS-D, and IBS-M).

Organic prebiotic fiber provides food sources supporting probiotic effectiveness while promoting growth of existing beneficial bacteria. The synbiotic combination enhances SCFA production, supporting gut barrier function and reducing inflammation that contributes to IBS symptom generation.

Delayed-release capsules protect bacterial viability through stomach acid exposure, ensuring therapeutic doses reach the intestines. The vegetarian capsules suit various dietary restrictions while maintaining stability at room temperature, eliminating refrigeration requirements.

The recommended one-capsule daily dose provides 60 billion CFU in a concentrated delivery system. Most users notice digestive improvements within 2-4 weeks, with maximum benefits emerging over 8-12 weeks of consistent use based on IBS clinical trial timelines.

Our Top Pick

Best for Immune Support: Physician's CHOICE Immune Formula

Check Price

Physician's CHOICE Probiotics 60 Billion CFU - 10 Strains + Organic Prebiotics - Immune, Digestive & Gut Health - Sup...

Check Price on Amazon

As an Amazon Associate we earn from qualifying purchases.

The Physician’s CHOICE Immune Support Formula delivers 60 billion CFU of targeted probiotic strains specifically researched for immune function enhancement and respiratory infection prevention. Meta-analyses show probiotic supplementation reduces upper respiratory infection frequency by 47 percent and duration by 1.89 days compared to placebo.

The strain selection emphasizes Lactobacillus and Bifidobacterium species with published immune research demonstrating enhanced natural killer cell activity, increased secretory IgA production, and balanced pro-inflammatory and anti-inflammatory cytokine responses. These mechanisms strengthen first-line immune defenses while preventing excessive inflammation.

Organic prebiotic fiber supports both probiotic effectiveness and existing beneficial bacteria populations. Research shows prebiotics independently support immune function through SCFA production and gut barrier strengthening, creating synergistic effects when combined with probiotics.

The delayed-release capsule technology protects bacterial viability through stomach acid, ensuring therapeutic doses reach intestinal immune tissues where 70-80 percent of immune system cells reside. The shelf-stable formulation maintains potency without refrigeration.

Recommended use is one capsule daily year-round for immune maintenance, with particular value during high-risk infection seasons. Clinical trials typically show immune benefits emerging within 4-6 weeks and requiring ongoing supplementation for sustained effects.

What Clinical Research Supports Probiotic Benefits?

Over 10,000 published studies examine probiotic effects on human health, with the evidence base expanding rapidly. However, the quality and applicability of research varies significantly. Understanding which health claims have robust clinical support versus preliminary or mixed evidence helps set realistic expectations.

Antibiotic-Associated Diarrhea Prevention

The strongest and most consistent evidence supports probiotic use for preventing antibiotic-associated diarrhea (AAD). Multiple meta-analyses demonstrate:

Lactobacillus rhamnosus GG: Reduces AAD risk by 51 percent across 23 randomized controlled trials involving over 3,000 participants (PubMed: 22570464). Benefits are most pronounced when probiotics are started within 48 hours of antibiotic initiation and continued throughout the antibiotic course plus 1-2 weeks after completion.

Saccharomyces boulardii: This beneficial yeast shows particular efficacy since it resists antibacterial medications, allowing simultaneous administration. Research demonstrates 60 percent reduction in Clostridium difficile infection risk when taken during antibiotic courses (PubMed: 23645497).

Multi-strain formulas: Combinations of Lactobacillus and Bifidobacterium species show consistent AAD prevention, with effectiveness increasing with higher CFU counts (typically 10-20 billion daily).

The mechanism involves maintaining beneficial bacterial populations despite antibiotic-induced disruption, competing with opportunistic pathogens like C. difficile for colonization sites, and supporting immune function during microbiome perturbation.

IBS Symptom Management

Irritable bowel syndrome affects 10-15 percent of adults, characterized by abdominal pain, bloating, and altered bowel habits without structural abnormalities. Probiotic research shows promising but strain-specific results:

Bifidobacterium infantis 35624: Clinical trials demonstrate 30-40 percent reductions in IBS symptoms including bloating, abdominal pain, and bowel movement irregularity across all IBS subtypes (PubMed: 23135760). This specific strain designation is critical—other B. infantis strains don’t show equivalent benefits.

Multi-strain Bifidobacterium formulas: Combinations of several Bifidobacterium species show statistically significant IBS symptom improvements, particularly for constipation-predominant IBS (IBS-C).

Lactobacillus plantarum 299v: Research demonstrates reductions in abdominal pain and bloating, though effects are more modest than Bifidobacterium strains.

IBS symptom improvements typically emerge over 8-12 weeks, requiring patience and consistent supplementation. Not all individuals respond equally—success rates in clinical trials range from 40-70 percent depending on IBS subtype and baseline severity.

Immune Function and Infection Prevention

Numerous studies examine probiotic effects on immune parameters and infection rates:

Upper respiratory infections: Meta-analyses show probiotic supplementation reduces respiratory infection frequency by 47 percent and duration by 1.89 days compared to placebo (PubMed: 21677116). Benefits are most consistent in children, older adults, and individuals under physical or psychological stress.

Immune cell function: Clinical trials demonstrate probiotics enhance natural killer cell activity, increase secretory IgA production at mucosal surfaces, and promote balanced pro-inflammatory and anti-inflammatory responses. These effects support first-line immune defenses while preventing excessive inflammation.

Vaccination responses: Some research suggests probiotics improve antibody responses to vaccines, though results vary by probiotic strain, vaccine type, and population studied.

The mechanism involves gut-associated lymphoid tissue (GALT) training, where 70-80 percent of immune cells reside. Probiotic bacteria interact with these immune cells, influencing systemic immune function beyond just digestive health.

Inflammatory Bowel Disease Management

Research on probiotics for Crohn’s disease and ulcerative colitis shows mixed results:

Ulcerative colitis: The multi-strain formula VSL3 (now called Visbiome due to legal disputes) demonstrates efficacy for inducing and maintaining remission in some UC patients. Research shows benefits comparable to standard medications in mild-to-moderate cases.

Pouchitis prevention: Probiotic therapy significantly reduces pouchitis (inflammation of surgically created intestinal pouches) following colectomy in UC patients. VSL3/Visbiome shows the strongest evidence for this specific application.

Crohn’s disease: Evidence is less convincing for Crohn’s disease management, with most studies showing minimal or inconsistent benefits. The distinct inflammatory mechanisms in Crohn’s versus UC likely explain differential probiotic responses.

IBD represents a more complex inflammatory condition than IBS, and probiotics should complement rather than replace standard medical management. Work with gastroenterologists when considering probiotics for IBD.

Mental Health and Mood

Emerging research explores the gut-brain axis and psychobiotic effects:

Anxiety and depression: Several small studies show probiotic supplementation reduces anxiety and depression symptoms, particularly in individuals with existing mood disorders. Research demonstrates improvements in stress hormone responses and inflammatory markers associated with depression.

Cognitive function: Preliminary research suggests certain strains may enhance memory, processing speed, and cognitive flexibility, though mechanisms remain under investigation.

Stress response: Probiotics appear to modulate cortisol responses and subjective stress perceptions in controlled trials, supporting stress resilience.

While promising, psychobiotic research remains in early stages with significant variability in strain effects, optimal dosing, and individual responses. Current evidence doesn’t support probiotics as primary mental health interventions but suggests potential adjunctive value.

Metabolic Health

Research examines probiotic effects on weight management, blood sugar control, and cholesterol:

Weight management: Results are inconsistent, with some studies showing modest weight loss (1-2 kg over 12 weeks) while others show no significant effects. Lactobacillus gasseri shows the most consistent weight management research, though effects remain modest.

Blood sugar control: Several trials demonstrate improved fasting glucose, HbA1c, and insulin sensitivity in type 2 diabetes patients supplementing with specific probiotic strains. However, effects are generally small and variable.

Cholesterol reduction: Meta-analyses show probiotics reduce total cholesterol by 6-8 mg/dL and LDL cholesterol by 7-8 mg/dL on average. While statistically significant, these reductions are clinically modest compared to statin medications.

Metabolic benefits appear most pronounced in individuals with existing metabolic dysfunction rather than healthy populations. Probiotics may support metabolic health as part of comprehensive lifestyle interventions but don’t replace diet, exercise, or medications when indicated.

How Do You Choose the Right Probiotic?

With hundreds of probiotic products available, selecting an effective formula requires understanding key quality markers and matching strains to specific health goals:

Strain Identification

Complete naming: Quality products list complete strain identification including genus, species, and strain designation. For example: “Lactobacillus rhamnosus GG” not just “Lactobacillus.”

Strain-specific research: Different strains within the same species exhibit different properties. Lactobacillus rhamnosus GG has extensive research for antibiotic-associated diarrhea prevention, while other L. rhamnosus strains may not show equivalent benefits.

Proprietary blends warning: Avoid products listing “proprietary probiotic blend” without specific strain identification. This blocks verification of research supporting claimed benefits.

CFU Count and Dosing

Clinically meaningful doses: Most research uses 10-100 billion CFU daily. Single-strain formulas may use lower doses (1-10 billion) while multi-strain products typically contain 10-60+ billion total CFU.

Guaranteed potency: Look for products guaranteeing CFU counts through expiration date, not just at time of manufacture. Bacterial viability decreases over time, so “manufactured with 50 billion CFU” means potency at expiration may be significantly lower.

Appropriate serving size: Verify the labeled CFU count reflects the recommended serving size. Some products require 2-3 capsules to achieve stated potency.

Survivability Features

Acid resistance: Probiotic bacteria must survive stomach acid (pH 1.5-3.5) to reach the intestines where they function. Look for:

• Delayed-release or acid-resistant capsules
• Enteric coating technology
• Spore-forming species (Bacillus) naturally resistant to acid
• Microencapsulation or other protective technologies

These features ensure bacteria survive stomach acid to reach the intestines where they function.

Third-Party Testing

Independent verification: Prefer products that undergo:

• Third-party testing for potency and purity
• Certification from organizations like ConsumerLab, USP, or NSF
• Regular batch testing by manufacturers

Numerous studies finding probiotic products contain different species or lower CFU counts than labeled highlight the importance of third-party verification.

Evidence-Based Formulation

Clinical research: Prioritize products containing:

• Specific strains with published clinical trials for your health goals
• Appropriate doses based on research protocols
• Strain combinations studied together (if multi-strain)

Be skeptical of products making broad claims without strain-specific references or those containing dozens of strains at very low individual doses.

Storage Requirements

Viability maintenance: Consider:

• Refrigerated products if you can maintain proper storage
• Shelf-stable products with stability data if refrigeration is impractical
• Expiration dates and how recently products were manufactured

While modern stabilization technologies improve shelf-stable product viability, refrigeration generally provides maximum bacterial survival.

What Are Common Probiotic Mistakes to Avoid?

Understanding common pitfalls helps maximize probiotic effectiveness:

Taking with hot beverages: Heat kills probiotic bacteria. Take capsules with room temperature or cool liquids, never with hot coffee or tea.

Inconsistent supplementation: Most probiotic strains don’t permanently colonize the gut, requiring ongoing supplementation for sustained benefits. Sporadic use provides minimal effects.

Insufficient duration: Many people discontinue probiotics after 1-2 weeks if they don’t see immediate results. Most benefits require 4-8 weeks to emerge, with some conditions (IBS, immune function) requiring 8-12 weeks.

Wrong strain for condition: Using Lactobacillus strains for IBS when research supports Bifidobacterium species, or taking general probiotics for specific conditions requiring particular researched strains.

Expecting unrealistic results: Probiotics provide meaningful but modest benefits for most conditions. They support health as part of comprehensive strategies but rarely produce dramatic standalone effects.

Ignoring diet: No probiotic can overcome persistently poor dietary patterns. Prioritize diverse plant foods, adequate fiber (25-35g daily), and fermented foods alongside supplementation.

Combining with antimicrobials without timing consideration: Take probiotics 2-3 hours apart from antibiotics or antifungals to avoid interference while still providing benefit.

Storage negligence: Exposing probiotics to heat, moisture, or light accelerates bacterial death. Follow storage instructions carefully.

Assuming all probiotics are identical: Different genera, species, and strains provide different benefits. Generic “probiotic” without strain specification blocks informed selection.

Neglecting prebiotic intake: Probiotic bacteria require prebiotic fiber for food and metabolic activity. Inadequate fiber intake limits probiotic effectiveness.

Related Reading

The Complete Guide to Prebiotics: Feeding Your Gut Microbiome

Digestive Enzymes vs Probiotics: Which Do You Need?

Best Probiotic Strains for Immune Support

Fermented Foods vs Probiotic Supplements

How to Heal Your Gut After Antibiotics

The Gut-Brain Axis: Probiotics for Mental Health

IBS Treatment Guide: Diet, Probiotics, and Lifestyle

• Postbiotics vs Probiotics: Which Is Better for Gut Health?
• Best Supplements for Gut Health: Probiotics, Prebiotics, and Digestive Enzymes Compared
• How Dogs Improve Human Gut Microbiome: Cross-Species Health Benefits
• Best Probiotics for Bloating and Gas: Strain-Specific Guide Based on Research
• Best Supplements for IBS: Probiotics, Fiber, and More Reviewed by Research

Conclusion: Making Informed Decisions About Probiotic Use

Your gut microbiome represents one of the most powerful levers for influencing overall health—from digestion and immunity to metabolism, mood, and disease prevention. Probiotics offer a scientifically supported tool for restoring and maintaining this critical ecosystem, but their effectiveness depends on informed selection and realistic expectations.

The evidence is clear: specific probiotic strains provide meaningful benefits for specific conditions. Lactobacillus rhamnosus GG and Saccharomyces boulardii dramatically reduce antibiotic-associated diarrhea. Bifidobacterium infantis significantly alleviates IBS symptoms. Various Lactobacillus and Bifidobacterium strains strengthen immune function and reduce respiratory infections. The key word throughout this research is “specific”—benefits don’t generalize across strains, even within the same species.

Successful probiotic use requires understanding this strain-specificity and choosing products accordingly. Look for complete strain identification, clinically meaningful CFU counts guaranteed through expiration, acid-resistant delivery systems, and third-party testing verification. Match your selection to research supporting specific strains for your health goals rather than assuming any probiotic will provide all benefits.

Remember that probiotics work best within comprehensive gut health strategies. No supplement can overcome persistently poor dietary choices, chronic sleep deprivation, unmanaged stress, or sedentary lifestyles. Prioritize the foundations: diverse plant foods providing 25-35g daily fiber, regular fermented food consumption, adequate sleep, stress management, and physical activity. Then use targeted probiotic supplementation to address specific needs or support recovery from microbiome-disrupting events like antibiotic therapy.

References

1. Claesson MJ, et al. (2012). “Gut microbiota composition correlates with diet and health in the elderly.” Nature, 488(7410):178-84. PubMed: 22797518

2. Eckburg PB, et al. (2005). “Diversity of the human intestinal microbial flora.” Science, 308(5728):1635-8. PubMed: 15831718

3. Turnbaugh PJ, et al. (2006). “An obesity-associated gut microbiome with increased capacity for energy harvest.” Nature, 444(7122):1027-31. PubMed: 17183312

4. Qin J, et al. (2012). “A metagenome-wide association study of gut microbiota in type 2 diabetes.” Nature, 490(7418):55-60. PubMed: 23023125

5. Hempel S, et al. (2012). “Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis.” JAMA, 307(18):1959-69. PubMed: 22570464

6. Szajewska H, et al. (2013). “Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea in children: a randomized double-blind placebo-controlled trial.” Aliment Pharmacol Ther, 38(3):299-307. PubMed: 23645497

7. O’Mahony L, et al. (2005). “Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles.” Gastroenterology, 128(3):541-51. PubMed: 15765388

8. Whorwell PJ, et al. (2006). “Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome.” Am J Gastroenterol, 101(7):1581-90. PubMed: 16863564

9. Ford AC, et al. (2014). “Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis.” Am J Gastroenterol, 109(10):1547-61. PubMed: 25070051

10. Hao Q, et al. (2011). “Probiotics for preventing acute upper respiratory tract infections.” Cochrane Database Syst Rev, (9):CD006895. PubMed: 21677116

11. Yan F, Polk DB. (2011). “Probiotics and immune health.” Curr Opin Gastroenterol, 27(6):496-501. PubMed: 21897224

12. Dimidi E, et al. (2014). “The effect of probiotics on functional constipation in adults: a systematic review and meta-analysis of randomized controlled trials.” Am J Clin Nutr, 100(4):1075-84. PubMed: 25099542

13. Kadooka Y, et al. (2010). “Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial.” Eur J Clin Nutr, 64(6):636-43. PubMed: 20216555

14. Sun J, Buys N. (2015). “Effects of probiotics consumption on lowering lipids and CVD risk factors: a systematic review and meta-analysis of randomized controlled trials.” Ann Med, 47(6):430-40. PubMed: 26340654

15. Messaoudi M, et al. (2011). “Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects.” Br J Nutr, 105(5):755-64. PubMed: 20974015

16. Gareau MG, et al. (2011). “Bacterial infection causes stress-induced memory dysfunction in mice.” Gut, 60(3):307-17. PubMed: 20966022

17. Plaza-Diaz J, et al. (2019). “Evidence of the anti-inflammatory effects of probiotics and synbiotics in intestinal chronic diseases.” Nutrients, 9(6):555. PubMed: 28555037

18. Gerritsen J, et al. (2011). “Intestinal microbiota in human health and disease: the impact of probiotics.” Genes Nutr, 6(3):209-40. PubMed: 21617937

19. Sanders ME, et al. (2019). “Probiotics and prebiotics in intestinal health and disease: from biology to the clinic.” Nat Rev Gastroenterol Hepatol, 16(10):605-616. PubMed: 31296969

20. Hill C, et al. (2014). “Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic.” Nat Rev Gastroenterol Hepatol, 11(8):506-14. PubMed: 24912386